The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study

European Urology

Volumn 53, Issue 1, 2008, Pages 118-125

  Mattei, Agostino ^a   Fuechsel, Frank G ^a   Bhatta Dhar, Nivedita ^a   Warncke, Sebastian H ^a   Thalmann, George N ^a   Krause, Thomas ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Fusion imaging; Lymphadenectomy; Prostate cancer; SPECT

Indexed keywords

COLLOID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE PROCESSING; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

AGED; HUMANS; INJECTIONS, INTRALESIONAL; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROGNOSIS; PROSTATIC NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36448992600     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.07.035     Document Type: Article

References (19)

1. Flocks R.H., Culp D., and Porto R. Lymphatic spread from prostatic cancer. J Urol 81 (1959) 194-196
2. Gervasi L.A., Mata J., Easley J.D., et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142 (1989) 332-336
3. Masterson T.A., Bianco Jr. F.J., Vickers A.J., et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 175 (2006) 1320-1324 discussion 1324-5
4. Joslyn S.A., and Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68 (2006) 121-125
5. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252-2255
6. Cuneo B, Marcille M. Topographie des ganglions-ilio pelviens. Bull Mem Soc Anat Paris. 1901. 6. ser.jt.III. 653-63.
7. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
8. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
9. Jansen L., Nieweg O.E., Kapteijn A.E., et al. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol 7 (2000) 624-630
10. Weckermann D., Dorn R., Holl G., Wagner T., and Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51 (2007) 1549-1558 (discussion 1556-8)
11. Carter H.B., Ferrucci L., Kettermann A., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521-1527
12. Wawroschek F., Vogt H., Weckermann D., Wagner T., Hamm M., and Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166 (2001) 1715-1719
13. Warncke S.H., Mattei A., Fuechsel F.G., Z'brun S., Krause T., and Studer U.E. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 52 (2007) 126-133
14. Takashima H., Egawa M., Imao T., Fukuda M., Yokoyama K., and Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171 (2004) 2268-2271
15. Burkhard F.C., Kessler T.M., Fleischmann A., Thalmann G.N., Schumacher M., and Studer U.E. Nerve sparing open radical retropubic prostatectomy-does it have an impact on urinary continence?. J Urol 176 (2006) 189-195
16. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Is pelvic lymph node dissection necessary in patients with a serum PSA < 10 ng/ml undergoing radical prostatectomy for prostate cancer?. Eur Urol 50 (2006) 272-279
17. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
18. Shih H.A., Harisinghani M., Zietman A.L., Wolfgang J.A., Saksena M., and Weissleder R. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 63 (2005) 1262-1269
19. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70 (2003) 303-310